LYTIR

Insider · SEC Form 4 · EVP&Pres, Merck Animal Heallth

DeLuca Richard R.

In the 12 months to Nov 19, 2026, on the open market: sold $15.3M of MRK. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $15.3M in total.Aug: Insider sales $6.7MNov: Insider sales $8.6MDecJanFebMarAprMayJunJulAugSepOctNov$8.6M
Insider purchases above the line: $0Insider sales below: $15.3M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. MRKSold: Merck & Co., Inc. Nov 12, 2026 58,185 shares filed Nov 16, 2026 112,955 shares held directly after, as filed filing $8.6M
  2. MRKSold: Merck & Co., Inc. Aug 12, 2026 11,699 shares filed Aug 12, 2026 2 transactions filing $1.5M
  3. MRKSold: Merck & Co., Inc. Aug 11, 2026 12,837 shares filed Aug 12, 2026 2 transactions filing $1.7M
  4. MRKSold: Merck & Co., Inc. Aug 10, 2026 20,784 shares filed Aug 12, 2026 134,703 shares held directly after, as filed filing $2.7M
  5. MRKSold: Merck & Co., Inc. Aug 6, 2026 6,050 shares filed Aug 10, 2026 3 transactions filing $789K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Planned sales (Form 144)

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Notices filed under this filer's SEC CIK in the same 12 months, newest first; the figure is the market value the notice states. Not every notice becomes a sale. Every recent notice

  1. MRKRICHARD ROBERT DELUCA JR filed Nov 12, 2026 Merck & Co., Inc. Officer 58,185 shares planned sale date 11/12/2026 filing $8.6M
  2. MRKRICHARD ROBERT DELUCA JR filed Aug 12, 2026 Merck & Co., Inc. Officer 11,699 shares planned sale date 08/12/2026 filing $1.5M
  3. MRKRICHARD ROBERT DELUCA JR filed Aug 11, 2026 Merck & Co., Inc. Officer 12,837 shares planned sale date 08/11/2026 filing $1.7M
  4. MRKRICHARD ROBERT DELUCA JR filed Aug 10, 2026 Merck & Co., Inc. Officer 20,784 shares planned sale date 08/10/2026 filing $2.7M
  5. MRKRICHARD ROBERT DELUCA JR filed Aug 6, 2026 Merck & Co., Inc. Officer 6,050 shares planned sale date 08/06/2026 filing $789K

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • MRK: option exercise or conversion (code M), 2 entries, Apr 29 to Nov 12, 2026
  • MRK: shares withheld for tax or exercise price (code F), 1 entry, Apr 29, 2026
Code F
Shares paid to, or withheld by, the company to cover an exercise price or the tax due on an award.
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.